Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Nornickel increased nickel output by 0.3%

10/28/24 GMKN

Lenta reported for 9 months of 2024 by IFRS

10/28/24 LENT

Lenta retail revenue for 9 months up 61%

10/28/24 LENT

Ozon opened its 40th fullfillment center

10/28/24 OZON

Rosseti Volga reported for 9 months of 2024 by RAS

10/28/24 MRKV

Rosseti Urals reported for 9 months of 2024 by RAS

10/28/24 MRKU

Permenergosbyt reported for 9 months of 2024 by RAS

10/28/24 PMSB

Volgogradenergosbyt reported for 9 months of 2024 by RAS

10/28/24 VGSB

VTB reported for 9 months of 2024 by IFRS

10/28/24 VTBR

Yakutskenergo reported for 9 months of 2024 by RAS

10/28/24 YKEN